SLAMF1 is required for innate resistance to Bd

To investigate whether innate resistance to Bd infection requires SLAMF1, we infected unvaccinated mice. SLAMF1^-/- mice died earlier (Fig 1A) and had 3.5 log more lung CFU than wild-type mice at the termination of the experiment (Fig 1B), indicating a deficit in innate resistance to fungal infection in SLAMF1^-/- mice.

Download:

• PNG
  larger image
• TIFF
  original image

Fig 1. SLAMF1 is required for innate resistance to Bd, in vivo killing and ROS/NO production by neutrophils and monocytes.

Survival (A) and lung CFU (B) 4 days post infection of SLAMF1 knockout (KO) and wild type (WT) mice infected with Bd. *p < 0.05, Kaplan Meier test for survival. CFU from at least 10 mice/group are expressed as Log₁₀ plotted with geometric mean ± geometric SD *p < 0.05, two tailed Mann-Whitney T test. In vivo killing assay: Dot plots show yeast-associated cells (alveolar macrophages, neutrophils and monocytes) and the percentages of cells containing dead (DsRed-, Uvitex+) vs. live (DsRed + , Uvitex+) yeast. Dot-plots are concatenated data for 5 mice/group *p < 0.05 vs KO, two tailed Mann-Whitney T test (C). Lung cells stained ex vivo with ROS or NO indicators DHR-123 or DAF-FM diacetate. Geometric MFI of staining is shown for yeast-associated neutrophils, monocytes, and alveolar macrophages *p < 0.05 two tailed Mann-Whitney T test (D). In vitro killing assay: neutrophils and monocytes were isolated from bone marrow of wildtype and SLAMF1 KO mice and cocultured with Bd yeast overnight at 37C. 8 replicates plated for CFU. *p < 0.05 vs. all other groups, two tailed Mann-Whitney T test (E + F).

https://doi.org/10.1371/journal.ppat.1014282.g001

Phagocytes including neutrophils, monocytes, and macrophages internalize and kill fungi [7]. To see if SLAMF1 impacts elimination of Bd by phagocytes in vivo, we used a DsRed viability reporter strain [8,9]. We assessed killing by phagocytes at 16 hours post-infection (hpi) when the burden of lung CFU was comparable between wild type and SLAMF1^-/- mice. The percentage of dead yeast in neutrophils and monocytes, but not alveolar macrophages, was reduced in SLAMF1^-/- mice vs. controls (Figs 1C and S1A). Thus, killing of Bd by neutrophils and monocytes is impaired in the absence of SLAMF1 [7]. While the percentage of killed yeast associated with neutrophils (26.9%) is lower than with monocytes (49.08%), the number of yeast-associated neutrophils is 4.3 times higher than yeast-associated monocytes (S1B Fig) indicating that innate resistance is mostly determined by killing of yeast by neutrophils. We thus focused on activation of neutrophils to understand how SLAMF1 promotes resistance.

Production of reactive oxygen species (ROS) and nitric oxide (NO) is essential and serves as a surrogate of innate antifungal resistance [8]. We investigated a link between these products and reduced in vivo killing by neutrophils in SLAMF1^-/- mice. ROS and NO staining were reduced in yeast-associated neutrophils and monocytes in SLAMF1^-/- vs. controls (Fig 1D) and was unaffected in alveolar macrophages.

To assess intrinsic killing by SLAMF1^-/- neutrophils and monocytes, we cocultured the cells with Bd in vitro. In contrast to the in vivo defect, in vitro killing of Bd was similar for SLAMF1^-/- and SLAMF1^+/+ neutrophils and monocytes. (Fig 1E and 1F). Thus, these SLAMF1^-/- phagocytes are not intrinsically impaired in killing Bd yeast. SLAMF1 must be required on other cells for antifungal function of neutrophils and monocytes in vivo.

Innate CD4⁺ T cells, TCRγδ⁺ T cells and monocytes express SLAMF1 and augment neutrophil killing of Bd in vitro

We stained lung cells for SLAMF1 16 hpi when lung CFU is similar between SLAMF1^-/- and control mice. Among 17 populations of myeloid and lymphoid cells surveyed, CD4⁺TCRβ⁺, TCRγδ⁺, MAIT cells and Ly6C^hi CCR2⁺ monocytes expressed SLAMF1 (Fig 2A). We next investigated whether these cells activate neutrophils in a SLAMF1-dependent manner. MAIT cells were excluded, as there were too few in the lung after infection and specific cre mice were unavailable to study the SLAMF1 on MAIT cells.

Download:

• PNG
  larger image
• TIFF
  original image

Fig 2. CD4⁺ T cells, TCRγδ⁺ T cells, and monocytes express SLAMF1 and augment phagocyte killing of Bd.

Ex vivo staining of lung leukocytes for SLAMF1. WT and SLAMF1 KO mice were challenged with Bd and lungs harvested at 16 hr post-infection. Lung cells were stained ex vivo with anti-SLAMF1 (CD150) mAb. SLAMF1 staining of cells from WT and SLAMF1 KO mice (shaded. The plots are concatenates from 5 mice/group. P values were calculated based on individual sample MFIs between WT and SLAMF1KO mice. p < 0.05 vs. KO for all cell types, two tailed Mann-Whitney T test (A). In vitro killing assay with candidate activating cells, neutrophils and Bd yeast (B) created in Biorender https://BioRender.com/lc170nt. Neutrophils were isolated from bone marrow of WT mice. Candidate cells were isolated from lungs of WT mice 16 hr after challenge. Neutrophils plus CD4⁺ T cells (C), TCRγδ⁺ cells (D) and monocytes (E) were cocultured with Bd yeast overnight. In (F), CD4⁺ T cells were co-cultured with Bd yeast and monocytes as the effector. 8 replicates plated for CFU. *p < 0.05 two tailed Mann-Whitney T test. Bars are geometric mean with 95% CI. Graphs representative of 5 (B), 2 (C), and 2 (D) experiments, respectively.

https://doi.org/10.1371/journal.ppat.1014282.g002

We established an in vitro coculture assay with yeast, neutrophils and each candidate cell type (Fig 2B). We used naïve neutrophils from bone marrow and SLAMF1⁺ candidate cells from lungs 16 hpi; cell purity was > 90% for CD4⁺ T cells and monocytes, and 56% for TCRγδ⁺ T cells (S2 Fig). Whereas neutrophils alone reduced yeast numbers (Fig 2C - 2E), the addition of CD4⁺ T cells, TCR-γδ⁺ T cells or monocytes to cocultures further reduced CFU (Fig 2C -2E). Thus, CD4⁺ T cells, TCRγδ⁺ T cells and monocytes augment neutrophil killing of fungi. CD4⁺ T cells also augmented fungal killing by monocytes (Fig 2F).

Conditional mice that lack SLAMF1 on innate lymphocytes or monocytes

We created mice where SLAMF1 is ablated on the target cell by Tamoxifen treatment. We validated commercial SLAMF1^fl/fl mice by creating Ella cre x SLAMF1^fl/fl mice that lack SLAMF1 in embryonic cells. They phenocopy SLAMF1 cell surface staining and resistance to Bd infection of SLAMF1 global knockout mice (S3A3-S3D Fig).

To test the role of SLAMF1 on target cells, we crossed SLAMF1^fl/fl mice with cell-specific Cre⁺ mice (S3E3-S3H Fig). We verified loss of SLAMF1 on target cells by FACS. At 16 hpi, CD4⁺ T cells from the lungs of CD4-Cre⁺ x SLAMF1^fl/fl mice showed reduced SLAMF1 staining vs. controls (S3E Fig). Likewise, SLAMF1 was reduced on TCRγδ⁺ T cells from TCRγδ-Cre⁺ x SLAMF1^fl/fl mice (S3F Fig) and monocytes from CCR2-Cre⁺ x SLAMF1^fl/fl mice (S3G Fig). Since wild type monocytes display limited SLAMF1, we used GFP as a surrogate marker to verify Cre activation and elimination of SLAMF1 after tamoxifen treatment on the cells from CCR2-Cre⁺ x SLAMF1^fl/fl mice (S3H Fig), but not controls.

CD4⁺ T cells and TCRγδ⁺ T cells require SLAMF1 to augment killing by neutrophils

To investigate whether CD4⁺ T cells, TCRγδ⁺ T cells and monocytes require SLAMF1 to augment neutrophil killing, we cocultured yeast and neutrophils with candidate cells from Cre⁺ and Cre^- conditional mice (Fig 3A). CD4⁺ T cells that lack SLAMF1 in CD4-Cre⁺ mice failed to augment neutrophil killing compared to CD4-Cre- controls (Fig 3B). Likewise, TCRγδ⁺ T cells from TCRγδ-Cre⁺ mice failed to augment neutrophil killing compared to Cre- controls (Fig 3C). Monocytes from CCR2-Cre⁺ mice did not differ from Cre^- controls in this assay (Fig 3D). Thus, only innate T-cells augment killing by neutrophils in a SLAMF1-dependent manner.

Download:

• PNG
  larger image
• TIFF
  original image

Fig 3. CD4⁺ T cells and TCRγδ⁺ T cells augment neutrophil killing in a SLAMF1-dependent manner and in vivo killing of Bd in conditional SLAMF1knockout mice.

In vitro killing assay with candidate activating cells from conditional SLAMF1 knockout mice (A) created in Biorender https://BioRender.com/71w6m5v. Neutrophils isolated from bone marrow of wild type mice were cocultured with Bd yeast and candidate activating cells from lungs of conditional CD4-Cre x SLAMF1^fl/fl (B), TCRγδ-Cre x SLAMF ^fl/fl mice (C), and CCR2-cre SLAMF1^fl/fl mice (D) harvested 16 hr post-infection. 8 replicates plated for CFU. Data representative of 3 assays. *p < 0.05, two tailed Mann-Whitney T test. Wild type (WT), SLAMF1 knockout (KO), conditional CD4-cre x SLAMF1^fl/fl mice, CCR2-cre x SLAMF1^fl/fl mice, and TCRγδ-cre x SLAMF1^fl/fl mice were infected with 2x10⁴ Bd yeast and lung CFU plated at 14 days post-infection. Cre⁺ mice lack SLAMF1 on corresponding conditional knockout mice, Cre^- mice served as wildtype littermate controls for the corresponding Cre⁺ knockout mice (E). *p < 0.05 two tailed Mann-Whitney T test. Bars represent geometric mean with 95% CI.

https://doi.org/10.1371/journal.ppat.1014282.g003

SLAMF1 on CD4⁺ T cells is indispensable for anti-fungal resistance in vivo

We challenged conditional knockout mice and analyzed lung CFU to determine dispensability of SLAMF1 on target cells. Similar to SLAMF1 global knockout mice, CD4-Cre⁺ mice that lacked SLAMF1 on CD4⁺ T cells had increased lung CFU vs. controls (Fig 3E). In contrast, we saw no difference in lung CFU between TCRγδ-Cre⁺ vs. Cre^- mice and CCR2-Cre⁺ vs. Cre^- mice (Fig 3E). Thus, SLAMF1 is indispensable on CD4⁺ T cells for host resistance but dispensable on TCRγδ⁺ T cells and monocytes.

Augmented neutrophil killing also requires SLAMF1 expression on neutrophils

CD4⁺ T cells and TCRγδ⁺ T cells required SLAMF1 to augment neutrophil killing in vitro. If these lymphocytes activate neutrophils by SLAMF1:SLAMF1 homotypic interactions, SLAM1 expression should be required on neutrophils. To test this, we cocultured CD4⁺ T cells and neutrophils from wild type or SLAMF1^-/- mice. Neutrophils alone from wild type or SLAMF1^-/- mice each reduced yeast numbers, confirming SLAMF1^-/- neutrophils have no intrinsic killing defect. The addition of CD4⁺ T cells from wild type mice reduced CFU in the wells with neutrophils from wild type but not SLAMF1^-/- mice (Fig 4A). Thus, homotypic SLAMF1 interaction between neutrophils and CD4⁺ T cells is required to augment killing by neutrophils.

Download:

• PNG
  larger image
• TIFF
  original image

Fig 4. Augmented neutrophil killing requires SLAMF1 expression on neutrophils and soluble factors.

In vitro killing assay with wild type or SLAMF1 KO neutrophils and CD4⁺ T cells from WT mice. Neutrophils from bone marrow of naive mice were cocultured overnight with Bd yeast and CD4⁺ T cells harvested from the lungs of WT mice 16 hrs post-infection (A). 8 replicates plated for CFU. *p < 0.05, two tailed Mann-Whitney T test. Format of in vitro transwell assay: activating cells that potentially produce soluble factor in the bottom well; sensing neutrophils in the top well. Bd yeast and neutrophils from bone marrow of naive wild type mice were placed in the top insert wells. Bd yeast, neutrophils, and CD4⁺ T cells harvested from the lungs of wild type mice 16 hr post challenge were placed in the bottom well (B) created in Biorender https://BioRender.com/lc170nt. Transwell system results after overnight coculture, 8 replicates plated for CFU (C). *p < 0.05, two tailed Mann-Whitney T test. Model for SLAMF1 functions (D) created in Biorender https://BioRender.com/2r3dje9: 1) Cell contact through SLAMF1: SLAMF1 homotypic interactions between neutrophils and CD4⁺ T cells are requisite for neutrophil activation. 2) Homotypic SLAMF1:SLAMF1 interactions generate soluble factors that also augment neutrophil killing of Bd yeast.

https://doi.org/10.1371/journal.ppat.1014282.g004

Unexpectedly, we saw no SLAMF1 expression on lung neutrophils from infected wild type mice (S4A Fig) despite in vitro results indicating SLAMF1 on neutrophils is required to augment killing. We surmised SLAMF1 on neutrophils could be internalized upon contact with Bd yeast in the lung, as the in vitro assay uses naïve neutrophils from bone marrow. Indeed, fresh neutrophils from the bone marrow of wild type mice display SLAMF1 (S4B Fig). We then tested if SLAMF1 on neutrophils is downregulated by exposure to Bd yeast in vitro. Neutrophils from wild type mice displayed SLAMF1 when cultured without yeast but not after coculture with yeast (S4C Fig). After coculture, we detected intracellular SLAMF1, suggesting the receptor had become internalized. Thus, early in infection, homotypic SLAMF1:SLAMF1 interactions between CD4⁺ T cells and neutrophils likely augment neutrophil killing of yeast. Yeast may subvert these events by binding the receptor themselves.

Mtb infection conversely enhances expression of SLAMF1 on human neutrophils [10]. That study concluded that SLAMF1 can regulate myeloid cell autophagy or Th1 responses against Mtb. Hence, SLAMF1 may offer a target for host directed therapy by increasing pathogen control or reducing tissue damage during infection.

Homotypic SLAMF1 interactions between innate CD4⁺ T cells and neutrophils augment fungal killing by neutrophils via production of soluble factors

We investigated whether homotypic SLAMF1 interactions between innate T cells and neutrophils yields soluble factors that activate neutrophils to kill Bd. We established a transwell assay where the lower well contained yeast, innate T cells and neutrophils, and the upper well contained only neutrophils and yeast. Soluble factors from the lower well could then pass the membrane to activate neutrophils in the upper well (Fig 4B). To verify that soluble factors pass through the 0.4 mm pores of the transmembrane, we used recombinant IFN-γ (17 kDA) to activate neutrophils and increase their release of ROS and pro inflammatory cytokines [11]. IFN-γ addition to the lower well augmented neutrophil killing of Bd in the top well (S4D Fig). Addition of CD4⁺ T cells to the bottom well augmented killing of yeast by neutrophils in both the bottom well and top well (Fig 4C). Thus, homotypic SLAMF1 interactions between CD4⁺ T cells and neutrophils yield soluble factors that also activates neutrophils. We conclude that augmented killing by neutrophils may result from SLAMF-1 mediated cell-contact or contact-dependent production of soluble factors or both (Fig 4D).

We previously reported that TCRγδ⁺ T cells and CD4⁺ T cells recruit and activate neutrophils and innate resistance to Bd infection [12]. We did not investigate the role of SLAMF1 in that study. The mechanics that activate these innate populations at the site of infection have not been fully identified to our knowledge. Homotypic SLAMF1 interactions between innate lymphocytes and neutrophils and associated release of soluble products may underpin such responses during Bd and other mucosal fungal infections (e.g., candidiasis), where neutrophil killing of fungi could result from SLAMF1 mediated cell-contact, contact-dependent production of soluble factors or both.

Our study raises questions about SLAMF1 that have implications for innate immunity to fungi and other intracellular microbes: SLAMF1 as a sensor of fungi and the receptor’s role in either phagocytosis or immune evasion; SLAMF1 induced signaling in lymphocytes and neutrophils; the identity of soluble factors released by SLAMF1 homotypic interactions; and the potential use of soluble SLAMF1 receptor for antifungal immunotherapy. Insights from such work will deepen understanding of diverse SLAMF1’s receptor functions that regulate innate immune interactions and provide the foundation for targeted host directed therapies.

Ethics Statement

Animal studies adhered to protocol M005891 approved by the IACUC of UW-Madison. Animal studies were compliant with provisions established by the Animal Welfare Act and the Public Health Services (PHS) Policy on the Humane Care and Use of Laboratory Animals.

Additional Methods are found in S1 Text.